September 12, 2016 by John Schultz and Chain Drug Review
Alex Gourlay, EnvisionRx, prescription drug market, Prime Therapeutics, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
2016, Issue 09-12-2016, Issues, News
DEERFIELD, Ill. — The partnership of Walgreens Boots Alliance Inc. (WBA) and pharmacy benefit manager Prime Therapeutics positions the companies to capture a larger share of the prescription drug market and better compete with such players as CVS Health. St. Paul, Minn.-based Prime, the nation’s fourth-largest PBM with 22 million members, is owned by 14
September 12, 2016 by Chain Drug Review
AmerisourceBergen, Stefano Pessina, Walgreens Boots Alliance
2016, Issue 09-12-2016, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) Inc. has raised its stake in AmerisourceBergen Corp. to nearly 24%. Late last month, WBA exercised warrants to buy 22,696,912 shares of AmerisourceBergen common stock for about $1.19 billion. The warrants, the second of two tranches, are part of a long-term partnership announced in March 2013 between AmerisourceBergen
September 8, 2016 by Chain Drug Review
Federal Trade Commission, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) said it’s working on store divestiture scenarios with the Federal Trade Commission to gain clearance for its $17.2 billion deal to acquire Rite Aid Corp. WBA said Thursday that it and Rite Aid “remain actively engaged” in talks with the FTC as the regulator reviews the acquisition, which
September 7, 2016 by CDR Blog and Chain Drug Review
Albertsons, Kroger, Rite Aid, Sareway Haggen, Walgreens, Walgreens Boots Alliance, WBA
CDR Blog, Leading Headlines
The suspense (or impatience?) continues to build in the investor and retailing communities as Walgreens Boots Alliance’s $17.2 billion deal to buy Rite Aid remains under review by the Federal Trade Commission. Lately, speculation has centered on Kroger as a potential buyer of stores that would be divested by WBA for the FTC to sign
August 29, 2016 by Chain Drug Review
Alex Gourlay, Jim DuCharme, PBM, pharmacy benefit management, Prime Therapeutics, specialty pharmacy, Walgreens, Walgreens Boots Alliance, WBA
Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill., and ST. PAUL, Minn. — Walgreens has entered into a long-term alliance with Prime Therapeutics, the nation’s fourth-largest pharmacy benefit manager, that will include the creation of a joint pharmacy services company. Under the partnership, Walgreens and Prime will combine their central specialty pharmacy and mail service businesses, the companies said Monday. The
August 26, 2016 by Chain Drug Review
AmerisourceBergen Drug Corp., Stefano Pessina, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. said on Friday that it had agreed with AmerisourceBergen Corp. to amend the second tranche of warrants held by WBA to purchase AmerisourceBergen common stock to allow immediate exercise of the warrants, giving WBA nearly 24% of AmerisourceBergen’s outstanding equity. The warrants were originally scheduled to be exercisable
August 6, 2016 by Greg Jacobson and Chain Drug Review
Boots, Emart, Gab-Soo Lee, hypermarket, Ornella Barra, Shinsegae Group, Walgreens Boots Alliance, WBA
2016, Issue 08-08-2016, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) has signed an agreement to form a franchise partnership with Emart Co., a subsidiary of South Korea’s largest retailer, Shinsegae Group. Under the terms of the partnership, the two companies will create a pharmacy-led health and beauty retail franchise in South Korea operating under the Boots banner.
August 6, 2016 by Jeffrey Woldt and Chain Drug Review
Ahold, Delhaize, Federal Trade Commission, Jeffrey Woldt, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA
2016, Featured Articles, Issue 08-08-2016, Issues, Leading Headlines, Opinion
It has been slightly more than nine months since Walgreens Boots Alliance agreed to acquire Rite Aid in a $17.2 billion all-cash transaction. Since that time, speculation about whether the Walgreens-Rite Aid merger will pass muster with the Federal Trade Commission has become a staple of discussion for people involved in community pharmacy and the
August 1, 2016 by Chain Drug Review
Adam Pellegrini, digital health, Fitbit, health care technology, mobile health, Walgreens Boots Alliance, Woody Scal
Retail News, Technology
SAN FRANCISCO — Walgreens Boots Alliance executive Adam Pelligrini is leaving the company to join activity tracker device maker Fitbit Inc. as vice president of digital health. Fitbit said Monday that Pellegrini is slated to start at the company on Sept. 6. He will be responsible for leading Fitbit’s efforts to connect its products, information,
July 25, 2016 by Brian Bossetta
Alex Gourlay, National Institutes of Health, PMI Cohort Program, USA Precision Medicine Initiative, Walgreens, Walgreens Boots Alliance, WBA
2016, Issue 07-25-2016, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) is participating in the USA Precision Medicine Initiative (PMI) Cohort Program. WBA said its participation is the result of a $20 million grant awarded to The Scripps Research Institute by the National Institutes of Health (NIH). Walgreens will help support patient enrollment and participation in the cohort
July 19, 2016 by Chain Drug Review
Boots, Emart, Gab-Soo Lee, Ornella Barra, South Korea, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) plans to form franchise partnership with Emart Co. Ltd., a leading hypermarket retailer in South Korea. WBA said the first Boots stores are slated to open before the end of the first half of next year. Under the agreement, the Boots stores will be located in shopping malls,
July 15, 2016 by CDR Blog
Federal Trade Commission, FTC, Rite Aid, Scott Mushkin, Stefano Pessina, Walgreens Boots Alliance, Wolfe Research
CDR Blog, Leading Headlines
It looks like Walgreens Boots Alliance is getting down to brass tacks in its negotiations with the Federal Trade Commission to acquire Rite Aid. The New York Post reported late Thursday evening that WBA is discussing store divestitures with the FTC and trying to get a bead on the number of Walgreens and/or Rite Aid
July 13, 2016 by Chain Drug Review
Bliss, Boots Retail USA, Meri Baregamian, Soap & Glory, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
NEW YORK — Beauty care veteran Meri Baregamian, a former executive at Walgreens Boots Alliance, has joined spa and beauty products company Bliss as chief executive officer. Bliss said Baregamian took the reins as CEO effective July 7. Previously, she served as vice president of sales for Boots Retail USA in the global brands division
July 8, 2016 by Chain Drug Review
Alex Gourlay, Brad Fluegel, FDA, Food and Drug Administration, National Institutes of Health, next-generation sequencing, Precision Medicine Initiative, Precision Medicine Initiative Cohort Program, Robert Califf, Walgreens, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens plans to participate in the U.S. Precision Medicine Initiative Cohort Program, part of a sweeping federal medical research initiative to help develop individualized care based on a person’s genomic makeup. Walgreens said it’s taking part in the PMI Cohort Program via an initial $20 million grant awarded to The Scripps Research